Lv52
940 积分 2024-10-18 加入
[Chinese guidelines for the diagnosis and treatment of pediatric growth hormone deficiency]
7小时前
待确认
Cagrilintide–semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study
3个月前
已关闭
Tirzepatide monotherapy in Chinese patients with early type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial (SURPASS-CN-MONO)
3个月前
已完结
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
3个月前
已完结
Tirzepatide for Weight Reduction in Chinese Adults With Obesity
3个月前
已完结
Impact of BMI and comorbidities on efficacy of once‐weekly semaglutide: Post hoc analyses of the STEP 1 randomized trial
4个月前
已完结
The pathogenesis of IgA nephropathy and implications for treatment
4个月前
已完结
Epidemiology and determinants of obesity in China
4个月前
已完结
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
7个月前
已关闭
皖公网安备34019202002308
